 |
Levagen®, also known as Palmitoylethanolamide (PEA), is a high-quality ingredient that offers greater immunity, sports recovery, joint health, sleep quality, and relief from occasional joint discomfort. Thanks to LipiSperse® technology, this award winning ingredient is available with enhanced bioavailability as Levagen®+ and is clinically demonstrated to be up to 1.75 times more bioavailable than standard PEA thanks to LipiSperse® technology. PEA can serve as an excellent substitute for cannabidiol (CBD) as it supports a balanced inflammatory response, provides relief from occasional discomfort and supports immune health, and much of these effects are derived from PEA’s effect on the endocannabinoid system by increasing levels of anandamide (AEA). Levagen®+ is available in various formats: soft gel capsules, hard piece capsules, effervescent tablets and powders, ready-to-mix powders, beverages or liquids, shots, and gels. With clinical studies dating from 2018 to current, Levagen®+ offers a wide range of benefits without CBD’s legal and regulatory concerns. |
